AU2001272417A1 - G-protein coupled receptor org3. - Google Patents

G-protein coupled receptor org3.

Info

Publication number
AU2001272417A1
AU2001272417A1 AU2001272417A AU7241701A AU2001272417A1 AU 2001272417 A1 AU2001272417 A1 AU 2001272417A1 AU 2001272417 A AU2001272417 A AU 2001272417A AU 7241701 A AU7241701 A AU 7241701A AU 2001272417 A1 AU2001272417 A1 AU 2001272417A1
Authority
AU
Australia
Prior art keywords
org3
coupled receptor
protein coupled
protein
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272417A
Inventor
Derek Gatherer
Morag A. Grassie
Colin Andrew Mclean Semple
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2001272417A1 publication Critical patent/AU2001272417A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU2001272417A 2000-05-24 2001-05-21 G-protein coupled receptor org3. Abandoned AU2001272417A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00304419 2000-05-24
EP00304419 2000-05-24
PCT/EP2001/005919 WO2001090189A2 (en) 2000-05-24 2001-05-21 G-protein coupled receptor org3.

Publications (1)

Publication Number Publication Date
AU2001272417A1 true AU2001272417A1 (en) 2001-12-03

Family

ID=8173019

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272417A Abandoned AU2001272417A1 (en) 2000-05-24 2001-05-21 G-protein coupled receptor org3.

Country Status (5)

Country Link
US (1) US20030152973A1 (en)
EP (1) EP1290174A2 (en)
JP (1) JP2003533999A (en)
AU (1) AU2001272417A1 (en)
WO (1) WO2001090189A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1309623A2 (en) * 2000-05-22 2003-05-14 Millenium Pharmaceuticals, Inc. G protein-coupled receptors from human clone "26908" and uses thereof
WO2003004530A1 (en) * 2001-07-06 2003-01-16 Bayer Aktiengesellschaft Regulation of human somatostatin receptor-like protein
US20040121395A1 (en) * 2002-12-23 2004-06-24 Goodnow Robert Alan Sequence #115 as a target for identifying weight modulating compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1171467A4 (en) * 1999-04-27 2002-07-31 Smithkline Beecham Corp Axor-27, a g-protein coupled receptor
EP1203023A1 (en) * 1999-08-17 2002-05-08 MERCK PATENT GmbH Pgpcr-3 polypeptides and dna sequences thereof
US20030082534A1 (en) * 1999-11-16 2003-05-01 Peter Lind Novel G protein-coupled receptors
CA2388865A1 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
EP1242448A2 (en) * 1999-11-17 2002-09-25 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
CA2392961A1 (en) * 1999-12-10 2001-06-14 Incyte Genomics, Inc. G-protein coupled receptors

Also Published As

Publication number Publication date
US20030152973A1 (en) 2003-08-14
WO2001090189A3 (en) 2002-03-14
WO2001090189A2 (en) 2001-11-29
JP2003533999A (en) 2003-11-18
EP1290174A2 (en) 2003-03-12

Similar Documents

Publication Publication Date Title
AU2001268471A1 (en) G-protein coupled receptors
AU2001228665A1 (en) Toll-like receptor
AU1956701A (en) G-protein coupled receptors
AU2001264657A1 (en) Crf receptor antagonists
AU2001234766A1 (en) G-protein coupled receptors
AU2001280785A1 (en) G-protein coupled receptors
AU2001264721A1 (en) G-protein coupled receptors
AU2001240021A1 (en) Diazafluorenone il-8 receptor antagonists
AU2001245724A1 (en) Il-8 receptor antagonists
AU2001243351A1 (en) Il-8 receptor antagonists
AU2001240097A1 (en) G protein-coupled receptors
AU2001251175A1 (en) G-protein coupled receptors
AU2001261814A1 (en) G-protein coupled receptors
AU2001296444A1 (en) G-protein coupled receptors
AU2001240019A1 (en) G-protein coupled receptors
AU2001263288A1 (en) Crf receptor antagonists
AU2001241896A1 (en) Il-8 receptor antagonists
AU2001253172A1 (en) Il-8 receptor antagonists
AU2001223882A1 (en) Receptor
AUPQ563400A0 (en) Novel receptor
AU2002212140A1 (en) Inflammation related g-protein coupled receptor
AU2001272417A1 (en) G-protein coupled receptor org3.
AU2001245605A1 (en) Il-8 receptor antagonists
AU2002307903A1 (en) G-protein coupled receptor
AU2001294619A1 (en) Adp-glucose receptor